REGEMAT 3D Develops Tailored PLA-Hydroxyapatite Scaffold Method for BoneRegeneration

Granada, Spain – December 23, 2024 – REGEMAT 3D announces the successful
implementation of a new lab method using PLA filaments enriched with hydroxyapatite
(HA), designed to produce bioactive scaffolds for bone regeneration and tissue
engineering applications.
This method, developed by the REGEMAT 3D Biofabrication and Cell Culture Lab,
leverages hydroxyapatite’s osteoconductive properties—a mineral naturally found in
human bone—to enhance the biocompatibility and mechanical performance of
PLA-based scaffolds.
By incorporating HA at varying concentrations (5%, 10%, 15%, and 20%), the scaffolds’
characteristics can be precisely adjusted to match the biological and structural needs of
specific regenerative applications.
This advancement represents another step forward in REGEMAT 3D’s mission to deliver
versatile and high-performance biomaterials to researchers and clinicians advancing
personalized therapies.
For more updates on our lab methods and technology pipeline, visit www.regemat3d.com